| General Information |
| Business: |
We provide implants, surgical instruments and AI-enabled software for spine fusion surgery. We are currently focused on lumbar spine surgery.
Our aprevo technology platform consists of AI-enabled software solutions, interbody implants custom designed for each patient and single-use surgical instruments.
Note: Net loss and revenue are for the 12 months that ended March 31, 2025.
(Note: Carlsmed, Inc. disclosed its IPO’s terms in its S-1/A filing on July 15, 2025, as follows: Carlsmed is offering 6.7 million shares at a price range of $14.00 to $16.00 to raise $100.5 million, if priced at the $15.00 mid-point of its range. Background: Carlsmed, Inc. filed its S-1 to go public on June 26, 2025, without disclosing the terms for its IPO. Estimated initial IPO proceeds were $100 million, a placeholder figure.)
|
| Industry: |
Medical Equipment & Devices |
| Employees: |
100 |
| Founded: |
2018 |
| Contact Information |
| Address |
1800 Aston Ave, Suite 100 Carlsbad, California 92008 |
| Phone Number |
(760) 766-1923 |
| Web Address |
https://www.carlsmed.com./ |
| View Prospectus: |
Carlsmed, Inc. |
| Financial Information |
| Market Cap |
$397.74mil |
| Revenues |
$32.3 mil (last 12 months) |
| Net Income |
$-25.12 mil (last 12 months) |
| IPO Profile |
| Symbol |
CARL |
| Exchange |
NASDAQ |
| Shares (millions): |
6.7 |
| Price range |
$14.00 - $16.00 |
| Est. $ Volume |
$100.5 mil |
| Manager / Joint Managers |
BofA Securities/Goldman Sachs/Piper Sandler |
| CO-Managers |
|
| Expected To Trade: |
7/23/2025 |
|
Day:
|
Wednesday |
| Quiet Period Expiration Date: |
Available only to Subscribers |
| Lock-Up Period Expiration Date: |
Available only to Subscribers |
| SCOOP Rating |
Available only to Subscribers |
| Rating Change |
Available only to Subscribers |
